Hospital
Covington County Hospital
Covington County Hospital was paid $7.21M by Medicaid between Jan 2018 and Dec 2024, across 96 billing codes. Its largest line is 99282, Emergency department visit for the evaluation and management, low to moderate severity — 14% of everything it billed.
33Billing provider infoCOVINGTON COUNTY HOSPITAL
COLLINS, MS 39428
COLLINS, MS 39428
33aNPI1215965249assigned 06/29/2006
33bProvider typeCritical Access Hospital
28Total paid$7.21M
24GClaims187,551
24DCodes billed96
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Mississippi
Rank by total paid#10 of 32
Median peer was paid$3.94M
This provider vs. median1.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 29,945 | $1.04M | |
| 2019 | 24,854 | $1.01M | |
| 2020 | 24,446 | $827K | |
| 2021 | 25,844 | $1.13M | |
| 2022 | 34,246 | $1.34M | |
| 2023 | 30,305 | $1.12M | |
| 2024incomplete | 17,911 | $739K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 14% | 13,063 | 10,979 | $1.04M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 12% | 8,954 | 7,260 | $831K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 11% | 3,966 | 2,937 | $772K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 6.3% | 8,091 | 6,471 | $455K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 5.8% | 3,131 | 2,546 | $417K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 4.6% | 5,104 | 4,355 | $330K |
| A0425 | Ground mileage, per statute mile | 4.6% | 6,871 | 4,701 | $328K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.8% | 9,685 | 6,993 | $271K |
| A0427 | Emergency ambulance ride, advanced life supportAmbulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | 2.8% | 3,203 | 2,646 | $203K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.4% | 1,986 | 1,632 | $175K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.3% | 3,783 | 3,176 | $169K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.2% | 1,787 | 1,509 | $159K |
84 more codes
| 71045 | Radiologic examination, chest; single view | 2.0% | 3,916 | $144K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.9% | 1,550 | $139K |
| A0429 | Emergency ambulance ride, basic life support | 1.8% | 2,585 | $132K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1.5% | 652 | $111K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.4% | 4,063 | $104K |
| 71046 | Radiologic examination, chest; 2 views | 1.3% | 2,498 | $94K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 1.3% | 658 | $92K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.3% | 2,385 | $91K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.2% | 964 | $86K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.2% | 4,292 | $84K |
| 87634 | 1.1% | 1,477 | $77K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 11,908 | $66K |
| 80053 | Comprehensive metabolic panel | <1% | 8,388 | $60K |
| 87400 | <1% | 3,910 | $44K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 158 | $39K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 980 | $39K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 237 | $34K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,132 | $32K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,206 | $32K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 407 | $31K |
| 73562 | <1% | 756 | $30K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 13,903 | $30K |
| 80061 | Lipid panel | <1% | 2,866 | $29K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,109 | $26K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,117 | $24K |
| D2930 | Prefabricated stainless steel crown - primary tooth | <1% | 67 | $24K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,600 | $22K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 120 | $20K |
| 83880 | <1% | 990 | $19K | |
| 84484 | <1% | 2,761 | $17K | |
| 73630 | <1% | 394 | $17K | |
| 74022 | <1% | 261 | $17K | |
| 83874 | <1% | 2,474 | $16K | |
| 87088 | <1% | 2,844 | $16K | |
| 82553 | <1% | 2,727 | $15K | |
| 81001 | <1% | 6,383 | $14K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 520 | $14K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 526 | $14K |
| 81025 | <1% | 2,297 | $13K | |
| 86738 | <1% | 880 | $11K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,655 | $11K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 468 | $10K |
| 82550 | <1% | 2,859 | $10K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 111 | $9K |
| 74018 | <1% | 200 | $9K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,760 | $8K |
| 87186 | <1% | 1,351 | $8K | |
| 87077 | <1% | 1,476 | $8K | |
| 73610 | <1% | 156 | $8K | |
| 87420 | <1% | 618 | $7K | |
| 87428 | <1% | 124 | $6K | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | <1% | 87 | $6K |
| 83735 | <1% | 1,408 | $6K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 64 | $5K |
| 86328 | <1% | 142 | $5K | |
| 87103 | <1% | 305 | $4K | |
| 80305 | <1% | 504 | $3K | |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | <1% | 82 | $3K |
| 73030 | <1% | 73 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 83 | $3K |
| 73130 | <1% | 69 | $3K | |
| 83690 | <1% | 611 | $3K | |
| 87581 | <1% | 47 | $1K | |
| 87899 | <1% | 127 | $1K | |
| 72100 | <1% | 15 | $1K | |
| 85610 | <1% | 550 | $1K | |
| 93923 | <1% | 14 | $965.12 | |
| 51701 | <1% | 17 | $950.84 | |
| 82150 | <1% | 151 | $724.26 | |
| 86308 | <1% | 110 | $616.07 | |
| 85730 | <1% | 171 | $586.24 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 44 | $546.09 |
| 87070 | <1% | 79 | $540.06 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 29 | $520.75 |
| 83605 | <1% | 69 | $471.42 | |
| 93041 | <1% | 18 | $242.36 | |
| 82607 | <1% | 37 | $225.20 | |
| 86592 | <1% | 93 | $197.28 | |
| 83655 | <1% | 15 | $152.60 | |
| 82746 | <1% | 22 | $145.53 | |
| 84439 | <1% | 16 | $73.74 | |
| 86140 | <1% | 18 | $41.94 | |
| 85018 | <1% | 15 | $29.82 | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 0% | 103 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRODGERS, JAMIE (ADMINISTRATOR)
| Provider | Location | Paid |
|---|---|---|
| Choctaw Regional Medical Center | Ackerman, MS | $12K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.